BICOS Stock Overview
Operates as a bioconvergence company in North America, Europe, Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
BICO Group AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr48.98 |
| 52 Week High | kr59.38 |
| 52 Week Low | kr27.01 |
| Beta | 2.34 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -87.05% |
Recent News & Updates
Recent updates
Shareholder Returns
| BICOS | GB Life Sciences | GB Market | |
|---|---|---|---|
| 7D | 0% | 5.7% | 1.3% |
| 1Y | n/a | -38.5% | 6.1% |
Return vs Industry: Insufficient data to determine how BICOS performed against the UK Life Sciences industry.
Return vs Market: Insufficient data to determine how BICOS performed against the UK Market.
Price Volatility
| BICOS volatility | |
|---|---|
| BICOS Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 8.2% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: BICOS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BICOS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 880 | Maria Forss | www.bico.com |
BICO Group AB (publ) operates as a bioconvergence company in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Biosciences, and Bioautomation. The Bioprinting segment offers products, solutions, and services that enable proliferation of 3D cell culture and 3D printing.
BICO Group AB (publ) Fundamentals Summary
| BICOS fundamental statistics | |
|---|---|
| Market cap | kr3.02b |
| Earnings (TTM) | -kr1.70b |
| Revenue (TTM) | kr2.40b |
1.3x
P/S Ratio-1.8x
P/E RatioIs BICOS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BICOS income statement (TTM) | |
|---|---|
| Revenue | kr2.40b |
| Cost of Revenue | kr673.10m |
| Gross Profit | kr1.73b |
| Other Expenses | kr3.43b |
| Earnings | -kr1.70b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
| Earnings per share (EPS) | -24.04 |
| Gross Margin | 72.01% |
| Net Profit Margin | -70.56% |
| Debt/Equity Ratio | 29.0% |
How did BICOS perform over the long term?
See historical performance and comparison